PilotStudyAssessSafeActiveSurveillancApproachLocalThe Pa w/BrainMetsUndergoinCNSPenetratSystemicThe

Part of paid clinical trials in Orange, California.

Sponsor
University of California, Irvine
Study ID
NCT07827001
Status
Recruiting
Apply to this trial

Conditions

  • Brain Cancer
  • Brain Cancer Metastatic
  • CNS Cancer
  • Nervous System Cancer

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Study Details

This is a Pilot clinical trial determining the safety of an active surveillance approach to local therapy in subjects with brain metastases. These are subjects who are undergoing CNS-penetrating systemic therapy.

Key Dates

First listed
Sep 18, 2026
Start date
Aug 4, 2026
Status verified
Sep 2026
Primary completion
Aug 31, 2028
Completion
Aug 31, 2028

Study Design

Enrollment
12 participants (estimated)

Arms

  • Arm: SingleArm
    CNS-Penetrating Systemic Therapy

Primary Outcome Measure

Feasibility of Enrolling Patients [ Time Frame: 1 year ]

Central Contacts

  • Chao Family Comprehensive Cancer Center University of California, Irvine
    1-877-827-8839
    [email protected]
  • University of California Irvine Medical

Locations (1)

FacilityCityStateZIPSite coordinators
Chao Family Comprehensive Cancer Center, University of California, IrvineOrangeCalifornia92868
Aaron Simon, MD
[email protected]
1-877-827-8839

Find similar trials in Orange, CA

Nationwide
Brain cancer trialsOncology trialsNeuro-oncology trials
By condition
Brain cancer
By specialty
OncologyNeuro-oncology
By research site
Chao Family Comprehensive Cancer Center, University of California, Irvine· Orange, CA

Related Studies